Access to innovative treatment\u00a0could be a\u00a0serious issue\u00a0for several patients in the state. Low awareness of treatment\u00a0choices, poor understanding of\u00a0the basics\u00a0of\u00a0finishing\u00a0the total\u00a0course of treatment, suboptimal\u00a0care\u00a0system, and affordability\u00a0are\u00a0among\u00a0the most important\u00a0barriers to\u00a0applicable\u00a0care\u00a0and achieving the nation\u2019s\u00a0upbeat.\u00a0we have a tendency to\u00a0believe in comprehensive programmes\u00a0to handle\u00a0these\u00a0problems\u00a0and ease access to\u00a0care\u00a0generally.<\/p>\n

\n
• Improving Patient Access to Our Innovative Treatment<\/span>\n
  \n
  1. Patient\u00a0help\u00a0Programme<\/strong>
     \nAffordability is\u00a0one of the greatest access barriers in India. As a developing country with medium per capita\u00a0financial gain\u00a0and big\u00a0socioeconomic\u00a0inequality,India\u00a0has been\u00a0troubled\u00a0to produce\u00a0quality\u00a0tending\u00a0that serves\u00a0everybody\u00a0throughout the\u00a0land. The Cure Cancer Awareness Society (CCAS)\u00a0was\u00a0simply launched in 2008 and remains\u00a0nisus\u00a0to higher its service. CCAS doesn’t\u00a0invariably\u00a0cowl\u00a0all sorts\u00a0of drugs\u00a0or full cycle of treatment;\u00a0therefore\u00a0treatment\u00a0price\u00a0becomes\u00a0a significant\u00a0deterrent for patients in\u00a0finishing treatment. Diseases that cause\u00a0money\u00a0catastrophe, like cancer, not\u00a0solely\u00a0have an effect on\u00a0the haves\u00a0however\u00a0additionally\u00a0the\u00a0disadvantaged. Therefore,\u00a0there’s an\u00a0essential\u00a0ought to\u00a0ease the access to our innovative treatment.<\/li>\n
  2. What we\u2019re doing<\/strong>
     \nSince 2008, we’ve got\u00a0been showing commitment\u00a0to assist\u00a0patients\u00a0assuaging\u00a0treatment\u00a0price\u00a0burden by providing patient\u00a0help programmes.<\/li>\n
  3. Our impact<\/strong>
     \nTo date\u00a0we’ve got\u00a0helped\u00a0over nine thousand patients nationwide to access seven\u00a0products\u00a0and that we\u00a0can\u00a0still\u00a0expand access to our medicines through this programme.<\/li>\n<\/ol>\n<\/li>\n<\/ul>\n
     \n
     1. \n
        \n
        1. <\/li>\n<\/ol>\n<\/li>\n<\/ol>\n\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div><\/div><\/div>